Annual Current Liabilities
$169.28 M
+$50.73 M+42.79%
December 31, 2024
Summary
- As of March 12, 2025, MDGL annual total current liabilities is $169.28 million, with the most recent change of +$50.73 million (+42.79%) on December 31, 2024.
- During the last 3 years, MDGL annual current liabilities has risen by +$92.44 million (+120.30%).
- MDGL annual current liabilities is now at all-time high.
Performance
MDGL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$169.28 M
-$8.57 M-4.82%
December 31, 2024
Summary
- As of March 12, 2025, MDGL quarterly total current liabilities is $169.28 million, with the most recent change of -$8.57 million (-4.82%) on December 31, 2024.
- Over the past year, MDGL quarterly current liabilities has increased by +$50.73 million (+42.79%).
- MDGL quarterly current liabilities is now -4.82% below its all-time high of $177.85 million, reached on September 30, 2024.
Performance
MDGL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MDGL Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.8% | +42.8% |
| 3 y3 years | +120.3% | +42.8% |
| 5 y5 years | +573.6% | +42.8% |
MDGL Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.3% | -4.8% | +120.9% |
| 5 y | 5-year | at high | +573.6% | -4.8% | +573.6% |
| alltime | all time | at high | +4742.0% | -4.8% | +4932.0% |
Madrigal Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $169.28 M(+42.8%) | $169.28 M(-4.8%) |
| Sep 2024 | - | $177.85 M(+42.1%) |
| Jun 2024 | - | $125.16 M(+9.5%) |
| Mar 2024 | - | $114.34 M(-3.5%) |
| Dec 2023 | $118.55 M(+2.3%) | $118.55 M(+18.9%) |
| Sep 2023 | - | $99.67 M(-0.0%) |
| Jun 2023 | - | $99.71 M(+1.4%) |
| Mar 2023 | - | $98.35 M(-15.1%) |
| Dec 2022 | $115.89 M(+50.8%) | $115.89 M(+17.2%) |
| Sep 2022 | - | $98.92 M(+17.7%) |
| Jun 2022 | - | $84.01 M(+9.6%) |
| Mar 2022 | - | $76.64 M(-0.3%) |
| Dec 2021 | $76.84 M(+65.0%) | $76.84 M(+10.8%) |
| Sep 2021 | - | $69.33 M(+22.2%) |
| Jun 2021 | - | $56.71 M(+16.2%) |
| Mar 2021 | - | $48.79 M(+4.8%) |
| Dec 2020 | $46.56 M(+85.3%) | $46.56 M(-5.7%) |
| Sep 2020 | - | $49.37 M(+9.0%) |
| Jun 2020 | - | $45.27 M(+76.1%) |
| Mar 2020 | - | $25.70 M(+2.3%) |
| Dec 2019 | $25.13 M(+197.6%) | $25.13 M(+62.5%) |
| Sep 2019 | - | $15.46 M(+25.6%) |
| Jun 2019 | - | $12.32 M(+17.8%) |
| Mar 2019 | - | $10.46 M(+23.8%) |
| Dec 2018 | $8.44 M(-16.0%) | $8.44 M(+27.1%) |
| Sep 2018 | - | $6.64 M(+22.2%) |
| Jun 2018 | - | $5.44 M(-13.6%) |
| Mar 2018 | - | $6.29 M(-37.4%) |
| Dec 2017 | $10.05 M(+109.5%) | $10.05 M(+18.0%) |
| Sep 2017 | - | $8.52 M(+32.4%) |
| Jun 2017 | - | $6.44 M(+9.0%) |
| Mar 2017 | - | $5.91 M(+23.0%) |
| Dec 2016 | $4.80 M(-90.3%) | $4.80 M(+22.6%) |
| Sep 2016 | - | $3.92 M(+16.4%) |
| Jun 2016 | - | $3.36 M(-61.1%) |
| Mar 2016 | - | $8.64 M(-82.5%) |
| Dec 2015 | $49.28 M | $49.28 M(+60.9%) |
| Sep 2015 | - | $30.63 M(-5.8%) |
| Jun 2015 | - | $32.52 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $30.92 M(+0.1%) |
| Dec 2014 | $30.89 M(-4.1%) | $30.89 M(-6.3%) |
| Sep 2014 | - | $32.96 M(+0.9%) |
| Jun 2014 | - | $32.67 M(+0.9%) |
| Mar 2014 | - | $32.37 M(+0.5%) |
| Dec 2013 | $32.21 M(+37.1%) | $32.21 M(+24.2%) |
| Sep 2013 | - | $25.93 M(+29.2%) |
| Jun 2013 | - | $20.07 M(+21.3%) |
| Mar 2013 | - | $16.55 M(-29.5%) |
| Dec 2012 | $23.49 M(+55.0%) | $23.49 M(+23.8%) |
| Sep 2012 | - | $18.96 M(+3.9%) |
| Jun 2012 | - | $18.25 M(+16.7%) |
| Mar 2012 | - | $15.64 M(+3.3%) |
| Dec 2011 | $15.15 M(-9.5%) | $15.15 M(-11.5%) |
| Sep 2011 | - | $17.12 M(+11.5%) |
| Jun 2011 | - | $15.35 M(-11.3%) |
| Mar 2011 | - | $17.31 M(+3.5%) |
| Dec 2010 | $16.74 M(+1.6%) | $16.74 M(+12.0%) |
| Sep 2010 | - | $14.95 M(+21.9%) |
| Jun 2010 | - | $12.27 M(-5.9%) |
| Mar 2010 | - | $13.04 M(-20.8%) |
| Dec 2009 | $16.47 M(-50.6%) | $16.47 M(-7.3%) |
| Sep 2009 | - | $17.76 M(-87.9%) |
| Jun 2009 | - | $146.36 M(+240.8%) |
| Mar 2009 | - | $42.95 M(+28.9%) |
| Dec 2008 | $33.32 M(+60.4%) | $33.32 M(+22.3%) |
| Sep 2008 | - | $27.24 M(+31.4%) |
| Jun 2008 | - | $20.72 M(+1.0%) |
| Mar 2008 | - | $20.52 M(-1.2%) |
| Dec 2007 | $20.77 M(+79.9%) | $20.77 M(+50.3%) |
| Sep 2007 | - | $13.82 M(-12.9%) |
| Jun 2007 | - | $15.87 M(+29.1%) |
| Mar 2007 | - | $12.29 M(+6.5%) |
| Dec 2006 | $11.55 M(-20.2%) | $11.55 M(-0.1%) |
| Sep 2006 | - | $11.55 M(-20.2%) |
| Dec 2005 | $14.47 M(+12.4%) | $14.47 M(-8.6%) |
| Mar 2005 | - | $15.83 M |
| Dec 2004 | $12.88 M(+268.3%) | - |
| Dec 2003 | $3.50 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual current liabilities year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly current liabilities year-on-year change?
What is Madrigal Pharmaceuticals annual total current liabilities?
The current annual current liabilities of MDGL is $169.28 M
What is the all time high annual current liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total current liabilities is $169.28 M
What is Madrigal Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, MDGL annual total current liabilities has changed by +$50.73 M (+42.79%)
What is Madrigal Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of MDGL is $169.28 M
What is the all time high quarterly current liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total current liabilities is $177.85 M
What is Madrigal Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, MDGL quarterly total current liabilities has changed by +$50.73 M (+42.79%)